Invest now in Preclinical Phase

The demonstration of true clinical proof-of-concept is a key value-creation step in the clinical development of a medicine.

Invest in the future. Invest in life science. We are looking for next 15 months seed capital to financing & reach till Clinical Phase I

1 mln €

Cover investment needs to reach and design the pre-clinical phase where the result of the solution discovered will be final confirmed, and prepare development of the first phase of the Pancreatic Cancer for early stage of Phase I. Included: Process management / R&D project with Micar Innovation / Research and Development Process / Building the management & operational teams for growth.

Our Roadmap

The demonstration of true clinical proof-of-concept is a key value-creation step in the clinical development of a medicine.

The business model

The business model is based on discovering drugs and developing drug until phase 2a “Proof of concept" (PoC) and licensing them to the best possible commercial partner.

We are open

Pancreatic Pharmaceuticals are always open for Licensing deals / M&A / Strategic Collaboration / Development Veterinary drug – companion animals (Licensing deals)

Partnerships

Pancreatic Pharmaceuticals searching strategic Partnerships / Collaborations with other Biotech / Big Pharma / CRO in Oncology therapeutic area.

Investment

We searching strategic Investment with other Biotech / Venture Capital / Angel Investors

Please see Pitch desk in PDF

Invest now in Preclinical Phase - Pancreatic Pharmaceuticals

Pancreatic Pharmaceuticals is transforming the treatment of chronic pain by advancing one of the largest, exclusively pain-focused clinical pipelines of novel, non-opioid therapies. We aim to bridge the safety and efficacy gaps in current approaches to chronic pain management.

Our Mission

Pancreatic Cancer is a growing problem – not only in terms of the significant number of people that are impacted and the burden this places on our healthcare system.